1 Bihl F, Bruggmann P, Castro Batänjer E, Dufour JF, Lavanchy D, Müllhaupt B, et al. HCV disease burden and population segments in Switzerland. Liver Int. 2022;42(2):330–9.
2 European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020;73(5):1170–218.
3 Keiser O, Giudici F, Mullhaupt B, Junker C, Dufour JF, Moradpour D, et al. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat. 2018;25(2):152–60.
4 World Health Organisation. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organisation; 2022.
5 Swiss Hepatitis Strategy Network. Swiss Hepatitis Strategy 2014–2030: It’s time to act now. Process Paper – A Living Document. Zurich: Swiss Hepatitis; 2019.
6 Hepatitis Schweiz. Apri Score Calculator: Swiss Hepatitis; 2022:
https://hepatitis-schweiz.ch/fachleute/hepatitis-c (abgerufen am 05.04.2023).
7 University of Liverpool. Interaction Checker: University of Liverpool:
https://www.hep-druginteractions.org (abgerufen am 05.04.2023).
8 Hepatitis Schweiz. The HepCare Project: Swiss Hepatitis; 2020:
www.hepcare.ch (abgerufen am 05.04.2023).